Sawai Pharma To Purchase US Generic Producer


Sawai Pharmaceutical, which is based in Japan, is set to purchase Upsher-Smith Laboratories for $1.05 billion. Sawai Pharmaceutical is looking to expand into the US market. The purchase will likely be completed by the end of June, and Upsher-Smith will become a wholly owned subsidiary of Sawai. Sawai has been focused on M&A lately, with the recent $736 million purchase of Sagent Pharmaceuticals.

Read the source article at the Nikkei Asian Review

About the Author

Related Posts

Leave a Reply